Lexington, MA, United States of America

Xinqin Fang


Average Co-Inventor Count = 8.4

ph-index = 8

Forward Citations = 201(Granted Patents)


Location History:

  • Chestnut Hill, MA (US) (2001 - 2003)
  • Lexington, MA (US) (2003 - 2012)

Company Filing History:


Years Active: 2001-2012

Loading Chart...
18 patents (USPTO):

Title: Xinqin Fang: Pioneer in Nitrosated Nonsteroidal Antiinflammatory Compounds

Introduction:

In the ever-evolving field of pharmaceutical innovations, Xinqin Fang has emerged as a leading inventor and researcher in the development of nitrosated nonsteroidal antiinflammatory compounds. With over 18 patents to his name, Fang has made significant contributions to the medical community. This article explores his latest patents, career highlights, collaborations, and the lasting impact of his work.

Latest Patents:

Fang's most recent patents revolve around the invention of nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and compositions comprising these drugs. Essentially, his inventions involve utilizing nitrosated NSAIDs in combination with other compounds to create novel therapeutic compositions. These compositions provide promising methods for treating inflammation, pain, fever, gastrointestinal disorders, and even ophthalmic diseases.

Career Highlights:

Fang has made a remarkable impact on the pharmaceutical industry through his work with esteemed companies like Nitromed, Inc. and Nicox S.A. During his career, he has demonstrated a deep understanding of the potential of nitrosated NSAIDs in addressing various medical conditions. His dedication and expertise in this field have spurred significant advancements in pharmacology.

Collaborations:

Throughout his career, Fang has collaborated with notable professionals, including David S. Garvey and Richard A. Earl. These collaborations have not only enhanced the effectiveness of his inventions but also enabled the exchange of knowledge and ideas. Working alongside accomplished colleagues has undoubtedly played a crucial role in Fang's success.

Conclusion:

Xinqin Fang's groundbreaking contributions to the field of pharmaceutical innovations, particularly in the development of nitrosated nonsteroidal antiinflammatory compounds, have revolutionized the way we approach the treatment of various medical conditions. With an impressive portfolio of patents and fruitful collaborations, Fang remains a prominent figure in the industry. His dedication to advancing medical science will continue to benefit countless patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…